We have assessed the efficacy and tolerability of vigabatrin (VGB) in 60 patients with drug-resistant focal epilepsy. VGB reduced seizures by ≥50% in 56% of the patients. VGB was most efficient in cryptogenic epilepsies, in younger patients, in patients with a single temporal focus and in the less severe epilepsies.
|Translated title of the contribution||Treatment with Vigabatrin in focal epilepsies: Retrospective study of 60 cases|
|Number of pages||2|
|Journal||Bollettino - Lega Italiana contro l'Epilessia|
|Publication status||Published - 1994|
ASJC Scopus subject areas
- Clinical Neurology